Ariad Pharmaceuticals (ARIA) Reports Q1 EPS In-Line
More News related to ARIA
- Morning Movers 11/09: EWBC, CVM, REV, CGEN, RSH Higher; CHDX, SRZ, GTN, RPRX, VSR Lower
- JP Morgan Upgrades Ariad Pharmaceuticals (ARIA) to Overweight
- ARIAD Pharma (ARIA) Posts Q3 Loss of 21c, Misses Views by 3c
- ARIAD Reports Third Quarter 2009 Development Progress and Financial Results
- Trading Radar for 11/05: Starbucks (SBUX), CBS Corp. (CBS), CVS (CVS), Toyota (TM), Thomson Reuters (TRI)
More News related to Earnings
- Verizon (VZ) Executive McAdam Buys 17K Shares
- Herbalife (HLF) CEO Enters Trading Plan Covering 732K Shares
Ariad Pharmaceuticals (Nasdaq: ARIA) reports Q1 EPS of ($0.26) versus the analyst estimate of ($0.26). Revenue for the quarter was $1.9 million, versus the consensus of $2.78 million.
Subscribe to EasyStockAlerts.com & Get real-time e-mail alerts when news hits your stocks!
Related Categories
EarningsStocks Mentioned
+0.26Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
